The objective of this study was to confirm the biological role of p38c in human gliomas. The expression profiles of p38c and hTERT in human glioma samples were detected by Western Blot and immunohistochemistry. RNA interference was performed in U251 cells by p38c silencing. Cell proliferation and apoptosis were assayed by CCK-8 and flow cytometric analysis, and then RNA and protein expression levels were measured by real-time RT-PCR and Western Blot, respectively. Telomerase activity assays and Caspase-3,-9 activation assays were also conducted. The results showed p38c had a positive correlation with the glioma's malignancy grade and that the treatment of U251 cells with p38c-siRNA inhibited proliferation and induced apoptosis. Correspondingly, hTERT expression and telomerase activity were down regulated and Caspase-3 and -9 activities were elevated. In conclusion, p38c may serve as an oncogenic factor promoting the growth and progression of gliomas and may become a useful therapeutic target.
T he p38 mitogen-activated protein kinases (MAPKs) contain four members (p38a, p38b, p38c, and p38d). In addition to a wide variety of biological functions, MAPKs differ in their expression patterns, substrate specificities, and sensitivities to inhibitors 1, 2 . It is known that p38 can serve as a tumor suppressor by negatively regulating the proliferation and survival of the cells [3] [4] [5] . Specifically, it is believed that p38a is the most important negative regulation factor because numerous studies have seen its effects by using inhibitors special for p38a/b, which fall to suppress p38c or p38d 6, 7 . Also known as MAPK12, ERK6, and SAPK3, p38c was first observed to be predominately in skeletal muscle, a negative regulator of stimulated glucose uptake in peripheral tissues 8 , and required for the maintenance of slow skeletal muscle size 9 . However, p38c has now been observed in several human cancer cell lines 10, 11 , and its pathway could modulate some processes involved in cellular malignant transformations, such as proliferation, cell cycle progression, or apoptosis [11] [12] [13] . Overexpressions of p38c were also detected in colon and breast cancer tissues, which positively correlated with a poor prognosis of breast cancer 12, 14 . These authors suggested that p38c played a potential oncogenic role in a cancer's development and progression.
Gliomas are the most common primary brain tumor, yet few studies have focused on p38, even though it is regarded as a strong promoter of tumor invasion, progression, and poor patient survival 15 . Importantly, the antiproliferation of glioblastoma cells induced by b-elemene was dependent upon p38 activation 16 . This shows p38, and possibly p38c, has a positive function in the tumorigenesis of gliomas. Therefore, we aimed to investigate the expression of p38c MAPK in glioma tissues and explore the relationships between p38c and the progression of glioma. These findings may suggest a new-targeted approach of p38c for future cancer therapy.
Results
Up-regulation of p38c and hTERT expression in gliomas. To determine the relationship between p38c expression and glioma grade, Western Blotting was performed from the samples of 71 astrocytic glioma patients (grade I: 10; grade II: 18; grade III: 24; grade IV: 19) and 5 control samples. As shown in Figure 1 (also Supplementary Figure S1 ), the expression level of p38c in high-grade glioma patients was significantly higher than that of the normal controls and low-grade glioma patients (P 5 0.0014). Consistent with these results, we observed a significant increased in the level of p38c according to the histological grade of astrocytomas from immunohistochemistry ( Figure 2 ). Similar data could also be examined when detecting the level of hTERT ( Figure 1 and 2, Supplementary Figure S1 ). Furthermore, there was a correlation between the two indexes (r 5 0.818, P 5 0.0006; Figure 1 ). All the results indicated that p38c overexpression might be associated with the malignant degree of gliomas and have a role in its pathogenesis. negative control siRNA-treated cells (13.01 6 1.62) and blank control U251 cells (14.22 6 1.14) (P 5 0.0013; Figure 3a) . Similar results were obtained when detecting the protein level of p38c and hTERT by Western blotting (Figure 3b&c , Supplementary Figure  S2) . Additinonally, the descent of hTERT correlated with p38c silencing (r 5 0.667, P 5 0.0294).
Downregulation of p38c by siRNA inhibited cell proliferation in U251 cells. To investigate cell proliferation, the CCK-8 assay was performed. Compared to the control group, the knockdown of p38c by siRNA reduced U251 cell proliferation to 46.99 6 2.3% (P 5 0.0009; Figure 4a ). Furthermore, it was discovered that the telomerase activity (IOD value) in p38c-silenced groups (303.3 6 11.6) was significantly decreased to those of the control groups (P 5 0.0010; Figure 4b ). Knockdown of p38c by siRNA in human U251 glioma cells resulted in cell apoptosis. Annexin V staining demonstrated that the amount of apoptotic cells in U251 cells transfected with p38c siRNA was significantly increased when compared to cells untreated and transfected with control siRNA (Figure 4d , e, and f). The percent of apoptosis increased from 3.20 6 0.02% in control groups to 11.97 6 0.41% in p38c silenced groups (P 5 0.0011). This result indicated that siRNA targeting p38c was able to induce apoptosis in glioma cells.
To further explore the role of p38c in the apoptotic-signaling pathway, we examined the activities of caspase-3 and caspase-9 ( Figure 4c) . A significant enhancement of the two indexes was observed in U251 glioma cells treated with p38c siRNA. The activity of caspase-3 was 103.2 6 1.74 in the treatment group compared with 43.98 6 0.64 (BC) and 46.49 6 0.94 (NC) in the control groups (P 5 0.0016). For caspase-9, the sequences were 42.21 6 1.67 (p38c/ siRNA), 24.28 6 0.69 (BC), and 26.24 6 0.89 (NC) (P 5 0.0018).
Discussion
Important causes of tumor related deaths from the central nervous system are gliomas characterized by an unlimited proliferation and progressive local invasion 17 . Unfortunately, the underlying molecular mechanisms that result in astrocytomagenesis, local invasion, and recurrence remain unclear and are a major obstruction in finding novel therapeutic strategies [18] [19] [20] . Many researches have shown that p38 MAPKs participated in tumorigenesis. p38 was also involved in the cytotoxicity of troglitazone (TGZ) in renal cell carcinoma (RCC) cell lines 7 , while its activation was obligate in tumor cell apoptosis induced by drugs 6, 21 . It was found that a lack of p38a abrogates the radiosensitizing effect of 5-Fluorouracil (5-FU) in colorectal HCT116 cell lines 22 . As to human gliomas, researches indicated that the tumor occurrence was closely related to the MKK3/p38 pathway activation, and inhibition of p38 by LY479754 greatly sensitized arrested glioma cells to cytotoxic therapies 15 . Studies also detectd that p38 activation was one of the major causes for the increased chemosensitivity to CDDP on glioma cells 23 Moreover, p38 inhibition was found to strongly reduce invasion of U251 glioblastoma cells in an inflammatory microenvironment 24 . However, all of these researches have evident limitations. Most of the time, the inhibition of p38 was accomplished through inhibitors aimed specially at p38a/b, such as SB202190 25 . Few reports addressed the p38c and p38d isoforms. Recent studies indicated that the Ras oncogene positively regulated the expression of p38c, which increases Ras-dependent growth or inhibits stress induced cell-death independent of phosphorylation 26 . This role that p38 played may be achieve by up-regulation of ERK (extracellular signal-regulated kinase) expression or banding with PTPH1 (Protein-tyrosine phosphatase H1) 13, 27 . Furthermore, p38c overexpression led to a marked cell cycle arrest in the G2/M phase 12 . All of these suggests p38c could be involved in the tumor process. Therefore, p38c was regarded as a potential drug target in recent experiments. It has been found that a depletion of p38c suppressed Ras transformation in rat intestinal epithelial cells 13 . Knockdown of p38c expression in mouse breast cancer cell lines 4T1 resulted in an obvious decrease in cell proliferation and colony formation in vitro and a dramatic retardation of tumorigenesis in vivo. In addition, down-regulation of p38c initiated the activation of AKT signaling. The effect of targeting p38c could be promoted by inhibition of this feedback loop with various PI3K/AKT signaling inhibitors 12 . Nonetheless, it was not known how p38c might play a role in glioma tumorigenesis.
In this study, we first examined the expression of p38c in gliomas of different degrees by Western Blot and immunohistochemistry. The data showed that p38c was positively correlated with the glioma's malignancy grade. Previous research has indicated that hTERT may represent an indicator of progression and poor prognosis 28 . Our result of hTERT expression corresponds with this characterization. Moreover, there was cooperativity in the expression of p38c and hTERT, which was also shown in sarcomas 29 . p38c silencing experiments showed that p38c was involved in the cell proliferation of glioma cells. Along with the downregulation of p38c by siRNA, the hTERT expression and telomerase activity both declined. Combined with the histological data above, we can deduce that hTERT may be a downstream target of p38c that participates in cell suppression in glioma. It is not known how the p38c in the cytoplasm is taken into nucleus and regulates hTERT expression. Up to now, available data didn't reveal the mechanism in detail [29] [30] [31] . However, the latest research has revealed that a lack of either p38c or p38d in K-Ras-transformed fibroblasts increased cell migration and MMP-2 secretion, and a lack of p38c led to increased cell proliferation as well as tumorigenesis 32 . Additionally, the p38a/b inhibitor SB203580 was found to have no effect on abrogating the inhibitory effect of TNFa on hTERT in myeloid cells 33 . It was confirmed that p38a phosphorylation decreases p38c protein expression via c-Jun-dependent ubiquitinproteasome pathways, whereas its inhibition increases cellular p38c concentrations, indicating an active role of p38a phosphorylation in negatively regulating p38c protein expression 26 . Therefore, these conflicting results suggest that the p38 MAPK expression distribution of each subtype and their interactions should be included in future research.
Our research also revealed that siRNA targeting p38c was able to induce apoptosis in glioma cells and reduce expression levels of Caspase-3/9. Recently, p38c was thought to induce cell apoptosis according to regulation of the cell cycle. One study presented that p38c deletion sensitizes cells to ultraviolet ray (UV) exposure, accompanied by prolonged S phase cell cycle arrest and an increased rate of apoptosis 11 . However, other tests performed in breast cancer cells indicated that p38c overexpression resulted in cell cycle arrest in the G2/M phase, loss of p38 could induce pleiotropic mitotic defects, and the majority of p38-depleted cells die at mitotic arrest or soon after abnormal exit from M-phase 10, 12 . This remains to be researched further.
In summary, our results indicated that p38c is likely to be an oncogenic factor promoting growth and progression in gliomas. Meanwhile, p38c induced tumorigenesis may act towards regulating the expression of hTERT. Therefore, p38c may be a potential therapeutic target in glioma.
Methods
Patient samples. Human surgical biopsy samples taken from 71 patients with glioma were collected at the time of primary resection in the Neurosurgery Department of the Xiangya Hospital of Central South University from June to October in 2011. None of the patients had received chemotherapy or radiation before surgery. Five specimens of traumatic brain injury were used as nonneoplastic controls. All specimens were assessed by a pathologist according to the WHO Classification of Tumors of the Central Nervous System (4th edition, 2007), which were divided into low-grade glioma and high-grade glioma. Informed consents were obtained from the patients involved. This study was approved by the Ethic Committee of the Xiangya Hospital of Central South University.
Cell culture and transfection. The human U251 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FBS), penicillin (50 IU/ml), and streptomycin (50 mg/ml). p38c siRNA (primers: 59-GGAAGCGUGUUACUUACA ATT -39(sense), 59-UUGUAAGUAACACGCU-UCCTT-39 (antisense)), and negative control siRNA were purchased from Shanghai GenePharma Co., Ltd. Before the transfection procedure, U251 cells were seeded (2 3 10 5 cells/well) on six-well plates and grown to 70% confluence. Lipofetamine TM 2000 (Invitrogen) was utilized for transfection according to the manufacturer's instructions. After incubation for 20 min at room temperature, the mixtures of lipofetamine 2000 reagent and respective siRNA were diluted with culture medium and added to each well. Forty-eight hours after transfection, cells were harvested for quantitative real-time PCR and Western Blot analysis.
Quantitative PCR. Real-time PCR was done using SYBR Green PCR Master Mix (ABI, 4309155) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served as an internal reference control. Primer sequences for p38c were 59-GCACAC-TGGATGAATGGAA-39 (forward) and 59-TCAGGTGGAAGGTGAAGGT-39 (reverse), while for GAPDH they were 5-CAATGACCCCTTCATTGACC-3 (forward) and 59-GACAAGCTTCCCGTTCTCAG-39 (reverse). Primers were obtained from Sangon Biotech (Shanghai, China).
Cell viability assay. The cell viability was evaluated by Cell Counting Kit-8 (CCK-8) assay (Shanghai Beyotime Biotechnology Ltd., #C0038) with process steps from the kit's instructions. The optical density (OD) at 450 nm was recorded on a Microplate Reader (Bio-Rad, Hercules, CA, USA). The relative cell proliferation rate (% of control) was expressed as the percentage of (ODtest 2 ODblank)/(ODcontrol 2 ODblank), where ODtest is the optical density of the cells given siRNA, ODcontrol is the control sample, and ODblank is of the wells without U251 cells. Each experiment was performed three times.
Telomerase activity assay. Activity of telomerase was determined with TRAP-silver staining Telomerase Detection Kit (Beijing Midwest Group Science and Technology Ltd., #NKJ15DLM). Briefly, 2 ml telomerase extraction was added to 50 ml of a solution containing 5 ul 103 TRAP buffer, 1 ml dNTPs, 1 ml Taq-DNA polymerase, 1 ml TS primer, 2 ml telomerase extraction, 39 ml DEPC H 2 O, and 1 ml CX primer. Then, the reaction mixture was subjected to 30 cycles of PCR amplification (94uC for 30 s, 50uC for 30 s, 72uC for 90 s, 72uC for 5 min.). PCR products (9 mL) were electrophoresed in 1 mL 103 loading buffer on 10% nondenaturating polyacrylamide gel (PAG) at 220 V for 120 min. A silver staining positive result was the appearance of a ladder with a 6 bp increment. According to the Gel imaging analysis system (Bioshine GelX 1650), telomerase activity was shown by relative absorbance (integrated optical density, IOD).
Detection of apoptosis. The apoptosis was investigated using the Annexin V-FITC & PI Apoptosis Detection Kit (ADL, A0001a). All operations were performed in accordance with the instructions of the kit. Briefly, 5 mL annexin V-FITC and 10 mL PI were used per sample. The apoptosis of the U251 Cells (%) was analyzed by flow cytometry using a Becton Dickenson FACScan flow cytometer and Cell Quest software.
Caspase-3,-9 activation assay. The activity of caspase-3 was detected by cleavage of chromogenic caspase-3 substrates Ac-DEVD-pNA (acetyl-Asp-Glu-Val-Asp pnitroanilide). Protein was extracted using ice-cold cell lysis buffer and total protein (1-3 mg/ml) was added to the reaction buffer containing 10 ul Ac-DEVD-pNA (2 mM), then incubated 60-120 min at 37uC. The free pNA cleaved from its precursor can be quantified using a spectrometer at 405 nm. A similar process was performed in the caspase-9 activity assay, but the substrates changed to Ac-LEHD -pNA (acetyl-Leu-Glu-His-Asp p-nitroanilide). Western blot analysis. The procedures below were implemented to both tissue samples and U251 cells. The total proteins were prepared using the Total Protein Extraction Kit (ProMab, USA) and assayed quantitatively using the Bradford Protein Assay Kit (Beyotime, China). After conventional electrophoresis with 12% SDS-PAGE, separated proteins were transported onto a NC membrane (Pierce, Rockford, USA). Subsequently, the membrane was incubated with primary antibody against p38c (SANTA, USA, 15800) or hTERT (Epitomics, USA, 151000) overnight at 4uC. After washing, the membrane was incubated with each corresponding secondary antibody before visualized by chemiluminescence. Mouse monoclonal GAPDH (ProMab, USA, 151000) was used as the primary Ab for control. The densities of Western blot bands were detected using the software Gel Pro4.0 with presentation of IOD (integrated optical density). The band intensity ratio of p38c or hTERT to GAPDH (p38c/GAPDH, hTERT/GAPDH) from the same electrophoresis run was analyzed.
Immunohistochemistry and criterion. Immunohistochemistry (IHC) staining of 3 mm sections of glioma samples was performed with the HRP-Polymer anti-Mouse/ Rabbit IHC Kit (Maixin_Bio, Fuzhou, China) in standard procedures. The primary antibodies were mouse monoclonal p38c antibody (Origene, Rockville, MD, USA, 15150) and rabbit monoclonal antibody against human telomerase reverse transcriptase (hTERT) (Abcam, Cambridge, MA, USA, 15400). The positive cells were yellowish-brown in the cytoplasm (p38c) or nucleus (hTERT) while unstained in negative cells.
Statistical analysis. SPSS 17.0 statistical software was used for the statistical analysis. Data was expressed as Mean 6 SEM. One-way analysis of variance (ANOVA) and the Student-Newman-Keuls tests were used to analyze the significance of differences between study groups. Data was considered statistically significant at p , 0.05.
